Literature DB >> 20739168

Exercise decreases plasma antioxidant capacity and increases urinary isoprostanes of IPF patients.

R Jackson1, C Ramos, C Gupta, O Gomez-Marin.   

Abstract

We tested whether markers of systemic oxidant stress were detectable in 29 typical IPF patients, and whether these increased after low level exercise. We obtained resting plasma for measurement of amino terminal pro brain natriuretic peptide (NT-proBNP), and plasma and urine samples for isoprostanes and total nitrite. Total antioxidant capacity (TAC) was measured in plasma, and H(2)O(2) was measured in urine. Subjects exercised at ˜50 W on a semi recumbent bicycle until limited by dyspnea. Samples were obtained immediately after exercise for measurement of the same variables. Plasma and urine samples were also obtained at rest from 6 normal individuals over 40 years of age solely to establish comparison values for NT-proBNP, nitrite, H(2)O(2) and TAC assays. Plasma NT-proBNP was high at rest and after exercise, suggesting pulmonary arterial hypertension. IPF patients' resting NT-proBNP concentrations apparently exceeded those of normal controls. IPF plasma isoprostanes at rest exceeded the normals. IPF urine isoprostanes increased significantly after exercise (P = 0.047 by signed rank test); and, plasma TAC decreased significantly after exercise (P < 0.001 by signed rank test). Neither plasma nor urine nitrite changed significantly after exercise. H(2)O(2) concentration was quite high after exercise in some IPF subjects' urine. IPF patients demonstrate systemic oxidant stress at rest detectable as increased isoprostanes in the circulation. An increase in urine isoprostanes and a decrease in plasma TAC after exercise suggest that reactive oxygen species (ROS) are produced during low level exercise done by IPF patients. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739168     DOI: 10.1016/j.rmed.2010.07.021

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

1.  Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation.

Authors:  Robert M Jackson; Orlando W Gómez-Marín; Carol F Ramos; Constanza M Sol; Meryl I Cohen; Ignacio A Gaunaurd; Lawrence P Cahalin; Diana D Cardenas
Journal:  Lung       Date:  2014-04-05       Impact factor: 2.584

2.  Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer.

Authors:  M Matuszewski; B Szymańska; A Długosz; B Małkiewicz; J Dembowski; A Piwowar
Journal:  Biomed Res Int       Date:  2018-11-29       Impact factor: 3.411

Review 3.  Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.

Authors:  Cristina Estornut; Javier Milara; María Amparo Bayarri; Nada Belhadj; Julio Cortijo
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

Review 4.  Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety.

Authors:  Renata G Mendes; Viviane Castello-Simões; Renata Trimer; Adriana S Garcia-Araújo; Andrea Lucia Gonçalves Da Silva; Snehil Dixit; Valéria Amorim Pires Di Lorenzo; Bruno Archiza; Audrey Borghi-Silva
Journal:  Front Rehabil Sci       Date:  2021-11-16

Review 5.  Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review.

Authors:  Alessandro G Fois; Panagiotis Paliogiannis; Salvatore Sotgia; Arduino A Mangoni; Elisabetta Zinellu; Pietro Pirina; Ciriaco Carru; Angelo Zinellu
Journal:  Respir Res       Date:  2018-03-27

Review 6.  Non-Invasive Measurement of Exercise-Induced Oxidative Stress in Response to Physical Activity. A Systematic Review and Meta-Analysis.

Authors:  Giulia Squillacioti; Fulvia Guglieri; Nicoletta Colombi; Federica Ghelli; Paola Berchialla; Paolo Gardois; Roberto Bono
Journal:  Antioxidants (Basel)       Date:  2021-12-17

7.  Aerobic Exercise Improves Pulmonary Fibrosis by Improving Insulin Resistance and Inflammation in Obese Mice.

Authors:  Xishuai Wang; Xuejie Yi; Donghui Tang
Journal:  Front Physiol       Date:  2022-01-18       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.